Byungkook Lee
Research & Development Scientist Eli Lilly
Qook Lee joined the BioTDR group at Eli Lilly as a Research Scientist in 2017 and currently serves as a Research Advisor (Engineer) in Lilly Genetic Medicine at the Lilly Seaport Innovation Center. His work has focused on developing oral GG and GGG delivery platforms using hydrogels, polymeric particles, minitablets, and other technologies for extended drug delivery platform. He has also contributed to the evaluation of formulation and analytical method development in the mRNA-LNP-based protein replacement therapeutic area, gene editing and LNP production process development and supported large animal study productions.
Seminars
Wednesday 29th April 2026
Polymeric Extended Peptide Drug Delivery Platforms for Improving Bioavailability
2:00 pm
- Showcasing polymeric microparticles for extended release
- Highlighting post treatment for improving controlled release profiles
- Identifying the gaps between in vitro and in vivo systems
NEW COMPANY
